C.et al (2022)
Ozempic contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist
There is also a bigger ongoing study with over 2,000 people to confirm these results and gather more information, which will continue for about 89 weeks
Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, et al
5 listener questions on SubQ insulin, peripheral vasopressin, calcium in Afib, bougie safety, and dirty epi drips are your topics ripped from the mailbag this week, and Swami and Scott are tearing through them in this fast-paced 2-part segment
GLP-1 mediates its actions by binding to its receptor (GLP-1R), which is localised at the cell surface, in target tissues